Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Healthcare stocks are widely considered a cornerstone of a retirement portfolio due to their resilience, long-term growth ...

Here's the list of options activity happening in today's session: These itemized elaborations have been created using the ...

Vertex's lineup will look transformed in five years, and the company should continue performing well beyond that time. It's ...

However, its low valuation could have investors wondering if now is the right time to take a chance on the business, ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to ...

For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Scilex Holding Company (SCLX – Research Report) ...